The anti-infective action of a new steroid-base combination (fluclorolone acetonide in FAPG base) with conventional antimicrobial substances.
D001623:Betamethasone / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004926:Escherichia coli / Q000187:drug effects / Q000302:isolation & purification; D005233:Fatty Alcohols / Q000627:therapeutic use*; D005446:Fluocinolone Acetonide / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D009355:Neomycin / Q000008:administration & dosage / Q000627:therapeutic use; D009824:Ointments; D014677:Pharmaceutical Vehicles; D011409:Propylene Glycols / Q000627:therapeutic use*; D012871:Skin Diseases / Q000188:drug therapy* / Q000382:microbiology; D013210:Staphylococcus / Q000187:drug effects / Q000302:isolation & purification; D013258:Steroids, Chlorinated / Q000008:administration & dosage / Q000627:therapeutic use; D014631:Valerates / Q000627:therapeutic use
D004338:Drug Combinations; D005233:Fatty Alcohols; D009824:Ointments; D014677:Pharmaceutical Vehicles; D011409:Propylene Glycols; D013258:Steroids, Chlorinated; D014631:Valerates; D005446:Fluocinolone Acetonide; D001623:Betamethasone; D009355:Neomycin